HUMAN PLATELET ANTIGENS (HPA) - ANVISA Registration 80134860216
Access comprehensive regulatory information for HUMAN PLATELET ANTIGENS (HPA) in Brazil's medical device market through Pure Global AI's free database. This Risk Class II medical device is registered under ANVISA number 80134860216 and manufactured by PROGENIKA BIOPHARMA S.L.. The registration is held by GRIFOLS BRASIL LTDA with validity until currently active (VIGENTE).
This page provides complete technical specifications for this device, regulatory compliance details, 5 similar products found using AI-powered semantic search, 1 companies making the same product including BIOARRAY SOLUTIONS LTD., and 1 recent registrations in the same technical category. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, helping global MedTech companies navigate ANVISA regulations, identify competitors, and discover partnership opportunities efficiently.

Janaina dos Santos de Miranda
🇧🇷 Brazil Regulatory Expert
Need help with your Brazil registration?
Contact Pure Global Brazil TeamDevice Details
Registration Details
80134860216
25351609891201586
02513899000171
Company Information
Dates and Status
Jun 20, 2016
VIGENTE
09/18/2025 19:00:01
HUMAN PLATELET ANTIGENS (HPA)
Kit BeadChip HPA
BIOARRAY SOLUTIONS LTD.
80391910017
Jan 06, 2025
IMMUNOHEMATOLOGY - COMPLEMENTARY REAGENTS
PLACAS CMT
IMMUCOR, INC
10077090118
Mar 01, 2017
IMMUNOHEMATOLOGY - RH-HR, KELL, KIDD, DUFFY - MONOCLONAL ORIGIN
ID CORE XT Reagents
Not specified
80134860219
Jul 04, 2016
IMMUNOHEMATOLOGY - RH-HR, KELL, KIDD, DUFFY - MONOCLONAL ORIGIN
ID CORE XT Reagents
PROGENIKA BIOPHARMA S.L.
80134860219
Jul 04, 2016
IMMUNOHEMATOLOGY - COMPLEMENTARY REAGENTS
H.P.C. – Human Platelet Concentrate
IMMUCOR, INC
10154450204
Jul 30, 2020